Repligen Corp (RGEN)

27.85
0.46 1.62
NASDAQ : Health Care
Prev Close 28.31
Open 28.18
Day Low/High 27.69 / 28.31
52 Wk Low/High 20.07 / 39.17
Volume 198.59K
Avg Volume 307.10K
Exchange NASDAQ
Shares Outstanding 33.64M
Market Cap 924.39M
EPS 0.30
P/E Ratio 114.50
Div & Yield N.A. (N.A)

Latest News

Repligen is Now Oversold (RGEN)

Repligen is Now Oversold (RGEN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Repligen Corp. At $22.50, Earn 18.1% Annualized Using Options

Commit To Buy Repligen Corp. At $22.50, Earn 18.1% Annualized Using Options

Investors eyeing a purchase of Repligen Corp. stock, but cautious about paying the going market price of $26.29/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Repligen Reports First Quarter 2016 Financial Results

Repligen Reports First Quarter 2016 Financial Results

Record quarterly revenue of $25.1 million, reflecting 21% year-over-year growth

Repligen To Report First Quarter 2016 Financial Results

Repligen To Report First Quarter 2016 Financial Results

Webcast and Conference Call to Be Held Thursday, May 5, 8:30 a.m. ET

Repligen Acquires Atoll GmbH

Repligen Acquires Atoll GmbH

Broadens portfolio, expands customer base and increases capabilities in growing pre-packed chromatography column market

Repligen Forms Scientific Advisory Board

Repligen Forms Scientific Advisory Board

Recognized Experts in Bioprocessing to Provide Input on Product Innovation and Portfolio Expansion for Repligen

April Corrections Bring … Well, Let's Concentrate on April

I have a plethora of indicators that say we should get some sort of correction.

Repligen Announces Extension Of Long Term Supply Agreement For Protein A

Repligen Announces Extension Of Long Term Supply Agreement For Protein A

- Reaffirms Position as Strategic Supplier of Affinity Ligands to GE Healthcare -

Repligen To Report Fourth Quarter And Full Year 2015 Financial Results

Repligen To Report Fourth Quarter And Full Year 2015 Financial Results

Webcast and Conference Call to be Held Thursday, February 25, 8:30 a.m. ET

Commit To Purchase Repligen Corp. At $17.50, Earn 19.7% Annualized Using Options

Commit To Purchase Repligen Corp. At $17.50, Earn 19.7% Annualized Using Options

Investors eyeing a purchase of Repligen Corp. shares, but cautious about paying the going market price of $22.29/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCR, DCUB, DVD, KLAC, QLGC Downgrades: ABG, AKAM, ATTU, BIO, BMY, BOKF, CHH, FFIV, HMC, HUBB, LLL, LRN, MJN, MLI, OSIS, RGEN, SCS, SP, TRN, URI, VLY, WERN, ZION Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Repligen Stock Sees Short Interest Decline 24.6%

Repligen Stock Sees Short Interest Decline 24.6%

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 571,244 share decrease in total short interest for Repligen Corp. , to 1,749,140, a decrease of 24.62% since 12/15/2015.

RSI Alert: Repligen (RGEN) Now Oversold

RSI Alert: Repligen (RGEN) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Repligen To Present At The Stifel 2015 Healthcare Conference

Repligen To Present At The Stifel 2015 Healthcare Conference

Wednesday, November 18, 8:00 a.m. EST

First Week of RGEN December 18th Options Trading

First Week of RGEN December 18th Options Trading

Investors in Repligen Corp. saw new options begin trading this week, for the December 18th expiration.

Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate

CORRECTION -- Repligen To Report Third Quarter 2015 Financial Results

CORRECTION -- Repligen To Report Third Quarter 2015 Financial Results

- Webcast and Conference Call to be Held Thursday, November 5, 8:30 a.m. ET -

Repligen To Report Third Quarter 2015 Financial Results

Repligen To Report Third Quarter 2015 Financial Results

- Webcast and Conference Call to be Held Thursday, November 6, 8:30 a.m. ET -

Repligen Stock Sees Short Interest Drop 11.4%

Repligen Stock Sees Short Interest Drop 11.4%

The most recent short interest data has been released by the NASDAQ for the 07/31/2015 settlement date, which shows a 392,926 share decrease in total short interest for Repligen Corp. , to 3,056,959, a decrease of 11.39% since 07/15/2015.

Repligen To Report Second Quarter 2015 Financial Results

Repligen To Report Second Quarter 2015 Financial Results

Webcast and Conference Call to be Held Thursday, August 6, 8:30 a.m. ET